Member Info for TheGord

It looks to me that they were dumping Monday & Tuesday then didn’t Wednesday or Thursday. Basing that solely on no share sales larger than 50/60K. They usually dump 100K shares and more. Who knows though.

What a boring day. Can’t remember the volume being this low in a while. Might explain why heights didn’t dump yesterday or today as far as I can tell. My post from yesterday saying similar weirdly was deleted. Maybe Heights are on this BB?

Is big news coming? Latest carrot that everyone’s dangling based on a later the normal account sign off. I pray it is, I need it urgently before I need to sell some shares, but years invested here have shown it’s unlikely.

Watching until another RNS comes announcing a deal or a leak happens prior to that this share will stay in the low/mid 30s or drop lower. Have patience as you say.

Maybe STS has seen the best results to date, they have withheld it whilst in discussions with the fda who are going to grant an AA 🤔

Probably absolutely nothing but interesting that there was no large heights sale today? 50K shares was the largest size sale that I can see albeit a few of them..

Baffles me that no one is interested in buying these shares given what we know and can expect.

We expecting an RNS today?

But this is the best I’ve seen for a long time coupled with commercial language being ramped up in broker notes…

Why aren’t we seeing some big buying given how remarkable the data is..if I had the cash I’d be piling in right now…where are they??

Thoughts on all the off book trades? Share swaps, heights offloading, buys??

Still deciding what to open today at..

Unbelievable on both counts.

Somethings got to give now surely? Someone surely has to bite. How much longer should/can BP wait before making a bid!?

I think some are concerned there won’t be anything left to sell by year end (P1B), provided it doesn’t slip in to 2026..

Yes, Avacta has previously presented posters at AACR meetings where the full abstract text was embargoed until shortly before the presentation. This practice aligns with AACR's standard embargo policies, especially for late-breaking and clinical trial abstracts.​

SITC

+3

AACR

+3

AACR

+3

For example, in 2024, Avacta presented data on AVA6000 at the AACR Annual Meeting. The abstract was released by AACR on April 5, 2024, just a few days before the presentation on April 9, 2024. This timing is consistent with AACR's policy of embargoing late-breaking and clinical trial abstracts until their scheduled release dates. ​

GlobeNewswire

+1

Avacta Therapeutics

+1

Avacta Therapeutics

Therefore, the embargoed abstract for Avacta's upcoming poster at AACR 2025 is not unprecedented and follows the established protocols for late-breaking and clinical trial presentations at the conference.​

They don’t care, they have no skin in the game and all the while being paid a fortune to steer and improve on someone else’s tech. They’ll just carry on treating us with disrespect until they are fortunate enough to strike a deal that meets their greed (in which case everyone will hail them as geniuses and say they had faith all along) or the company indeed does go bust and they’ll move on the next potential holy grail. Im still holding but I won’t be buying again that’s for sure. I’m convinced the only investors who will make money here (if it does indeed all go to plan) will be ones who join a raise sometime next year) because I don’t see the board doing a deal until early/mid next year if that. Good luck all.

Was it showing as a buy at least?

At least Viking is entertaining, Wynbore 🫣

So why bombard the board, move on!